Amwell CFO Mark Hirschhorn Expands Leadership Role
18 Dezembro 2024 - 6:30PM
Amwell® (NYSE: AMWL), a leader in digital care, has announced
Chief Financial Officer (CFO) Mark Hirschhorn will take on an
expanded role as chief operating officer, effective Jan. 1, 2025.
Hirschhorn will now oversee the company's operational and growth
strategies, including the clinical, sales and marketing teams,
while continuing his responsibilities as CFO. This move reflects
Amwell’s commitment to scale its innovative solutions to meet the
growing demand for digital healthcare.
"Since joining Amwell, Mark has proven himself to be a strong
leader, and we’re thrilled to have him step into this expanded
role," said Ido Schoenberg, M.D., CEO and chairman of Amwell.
"Mark’s operational experience, coupled with his extensive
financial acumen, will help us continue to streamline the Amwell
portfolio of services and pursue core channels of profitable growth
while powering the digital care aspirations of our clients. With
these changes, we enable a higher level of focus on our mission of
connecting and empowering providers, insurers, and innovators to
deliver more accessible, affordable, high-quality care for the
benefit of all stakeholders. We also solidify our confidence in our
path to cash flow positive in 2026."
"I am eager to take on the additional responsibilities as COO,"
said Hirschhorn. "I look forward to working closely with our
talented and streamlined leadership team to sharpen our operational
focus on key priorities, drive greater efficiencies, optimize cash
flow and deliver profitable growth while pursuing our mission to
redefine healthcare delivery through technology-driven
solutions."
As Amwell continues to streamline processes and drive alignment,
two executives will leave the company. Chief Commercial and Growth
Officer Kathy Weiler, and Chief Operating Officer Kurt Knight, will
depart Amwell at the end of the year. Over her tenure, Weiler has
contributed to meaningful cost initiatives while transforming the
company’s growth organization. Knight has provided substantial
leadership over his 14-year tenure, including key roles in
strategy, M&A, the company’s IPO, rapidly scaling operations
through the COVID-19 pandemic, and building and managing the
company’s affiliated network of providers, Amwell Medical Group®, a
strategic service for payer and provider organizations.
“Kathy’s leadership led to the creation of a formally structured
and professionalized growth organization, which has had a
meaningful and lasting impact on our business. Kurt is a
foundational partner in Amwell. He has made an incredible
contribution to our company over many years. He played a major role
in transforming Amwell into the company it is today, and I am
forever grateful. I thank both leaders for their contributions to
Amwell,” said Schoenberg.
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in
the United States and globally, connecting and enabling providers,
payers, patients, and innovators to deliver greater access to more
affordable, higher quality care. Amwell believes that hybrid care
delivery will transform healthcare. We offer a single,
comprehensive platform to support all digital health needs from
urgent to acute and post-acute care, as well as chronic care
management and healthy living. With nearly two decades of
experience, Amwell powers the digital care of more than 50 health
plans, which collectively represent more than 100 million covered
lives, and many of the nation’s largest health systems. For more
information, please visit https://business.amwell.com/.
©2024 American Well Corporation. All rights reserved. Amwell®,
SilverCloud®, Amwell ConvergeTM, CarepointTM , Amwell Medical
Group®, and the Amwell Logo are registered trademarks or trademarks
of American Well Corporation.
Notice of OwnershipAll materials contained
herein are the property of American Well Corporation and are
copyrighted under United States law and applicable international
copyright laws and treaty provisions. The materials contained
herein are not work product or "work for hire" on behalf of any
third party. The materials contained herein constitute the
confidential information of American Well Corporation, except for
specific data elements provided by third parties, which are the
confidential information of such third parties. The content
contained herein results from the application of American Well
proprietary processes, analytical frameworks, algorithms, business
methods, solution construction aids and templates, all of which are
and remain the property of American Well Corporation.
Trademark NoticeAll of the trademarks, service
marks and logos displayed on these materials (the "Trademark(s)")
are registered and unregistered trademarks of American Well
Corporation or third parties who have licensed their Trademarks to
American Well Corporation. Except as expressly stated in these
terms and conditions, you may not reproduce, display or otherwise
use any Trademark without first obtaining American Well
Corporation's written permission.
Media:
Angela Vogen
Press@amwell.com
Investors:
Sue Dooley
Sue.Dooley@amwell.com
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024